Compounded ED Medications Explained: Are They Safe in 2026? (503A Guide)

Advertiser Disclosure
BestMedsHub may receive compensation from companies featured on this page. This compensation may impact how and where products appear. Our editorial assessments are independent and reflect our medical reviewer’s read of the public clinical and regulatory record.

By BestMedsHub Editorial Team · Medically reviewed by Dr. Marcus Tan, MD

Published May 27, 2026 · Updated May 27, 2026 · 14 min read

Compounded ED medications like Ro Sparks, Hims Hard Mints, and BlueChew Max are legal under federal law and made by licensed 503A compounding pharmacies. They are not FDA-approved as finished products, but their individual active ingredients — sildenafil and tadalafil — have decades of human safety data behind them. The real risks of compounded ED meds are dose variability and inconsistent pharmacy quality, not the underlying chemistry. In this guide we walk through what 503A compounding actually means, why these products skip FDA approval as a finished combo, what the science says about combining sildenafil and tadalafil in one dose, and how to evaluate a compounding pharmacy before you order.

These products are reasonable for healthy adult men who want a convenient single-dose ED treatment, who have been screened by a licensed prescriber, and who have no cardiovascular contraindications. They are not appropriate for anyone taking nitrates (absolute contraindication), anyone with unstable cardiovascular disease, anyone who hasn’t completed a real medical intake, or anyone buying from a source they can’t verify against a state pharmacy board. If a “compounded sildenafil” listing shows up on a marketplace or social-media ad without a prescriber and a named licensed pharmacy attached, treat it as counterfeit until proven otherwise.

Quick facts

What is a 503A pharmacy?

A state-licensed compounding pharmacy that prepares medications for individual patients with a valid prescription, under Section 503A of the federal Food, Drug, and Cosmetic Act.

What is a 503B facility?

An “outsourcing facility” that compounds in bulk for hospitals and clinics, registered with the FDA and subject to current good manufacturing practices (cGMP). Most telehealth-prescribed compounded ED meds do not come from 503B facilities.

Are compounded ED medications legal?

Yes — under federal law, when prepared by a licensed pharmacy in response to a valid individual prescription from a licensed prescriber.

Are they FDA approved?

The finished compounded product is not FDA approved. The active ingredients (sildenafil, tadalafil) are FDA approved as standalone drugs.

Who can prescribe them?

Any U.S.-licensed prescriber acting within their state’s scope of practice — typically MDs, DOs, NPs, and PAs working through telehealth platforms or in person.

Does insurance cover them?

Almost never. Compounded medications fall outside the FDA-approved formulations most insurers and PBMs reimburse. HSA/FSA reimbursement is sometimes possible with a letter of medical necessity.

Common products in 2026

Ro Sparks (sublingual sildenafil + tadalafil), Hims Hard Mints (chewable sildenafil + tadalafil), BlueChew Max (chewable sildenafil + tadalafil), plus generic compounded sildenafil 25–100 mg from various 503A pharmacies.

Real risks

Dose variability between batches, contamination if USP 795/797 standards are skipped, no FDA-vetted labeling, no insurance coverage, and ingredient purity that is difficult to independently verify.

Pharmacy accreditation to look for

PCAB (Pharmacy Compounding Accreditation Board) accreditation, plus an active license with the state board of pharmacy where the pharmacy operates and ships from.

Who should avoid them

Anyone on nitrates, anyone with severe cardiovascular disease, anyone with severe hepatic or renal impairment, and anyone who cannot verify the dispensing pharmacy’s licensure and accreditation.

What “compounded medication” actually means (in 60 seconds)

A compounded medication is one that a licensed pharmacist physically prepares from raw or finished pharmaceutical ingredients to match a specific prescription. Compounding is older than the modern pharmaceutical industry — it’s how every prescription was filled before mass manufacturing, and it’s still how pharmacists handle situations where an off-the-shelf FDA-approved product doesn’t fit a particular patient (pediatric dosing, allergy to a dye, a discontinued formulation, two drugs combined into one form factor).

The key distinction the FDA draws is between manufacturing a drug (mass production for general distribution, which triggers the full new-drug approval pathway) and compounding a drug (preparing it for an identified patient with a valid prescription, which sits under Section 503A). Compounded ED medications like Ro Sparks and Hims Hard Mints are technically prescription-specific preparations from 503A pharmacies, not mass-manufactured drugs. That’s why they don’t go through the same NDA process as branded Viagra or Cialis, and why their finished form isn’t FDA-approved.

This distinction matters because it sets the legal and regulatory frame for everything that follows. Compounding isn’t a workaround or a loophole — it’s a deliberate legal pathway. But it does come with trade-offs the FDA-approval pathway doesn’t have, and those trade-offs are exactly where the legitimate safety questions live.

Section 503A vs 503B: the two types of compounding pharmacies

The federal Food, Drug, and Cosmetic Act recognizes two distinct categories of compounders, and the difference between them is the single most important regulatory concept in this space.

Section 503A pharmacies are traditional state-licensed compounding pharmacies. They compound medications for individual patients in response to valid individual prescriptions. They are regulated primarily by state boards of pharmacy (not directly by the FDA), and they must comply with United States Pharmacopeia (USP) chapters 795 (non-sterile compounding) and 797 (sterile compounding). They cannot legally compound in bulk for general distribution, and they cannot compound products that are essentially copies of commercially available FDA-approved drugs unless there’s a documented clinical reason (a shortage, a patient-specific need, or a different dosage form like the sublingual or chewable formats used for ED).

Section 503B outsourcing facilities, by contrast, are registered with the FDA, inspected by the FDA, and must follow current good manufacturing practices (cGMP) — the same quality framework that applies to commercial drug manufacturers. They can compound in bulk without patient-specific prescriptions, typically to supply hospitals, clinics, and surgery centers. 503B facilities have a meaningfully higher regulatory bar than 503A pharmacies.

The compounded ED medications you encounter through telehealth in 2026 — Ro Sparks, Hims Hard Mints, BlueChew Max, generic compounded sildenafil from boutique pharmacies — are almost all dispensed by 503A pharmacies, not 503B facilities. That’s not necessarily a problem, but it does mean the FDA isn’t directly inspecting the facility that makes your specific batch. The quality floor depends on the state board, the pharmacy’s internal SOPs, and (ideally) voluntary PCAB accreditation.

Are compounded ED medications FDA approved? (the honest answer)

No — and the honest version of that answer has three layers worth understanding.

Layer 1: the active ingredients are FDA approved. Sildenafil was approved as Viagra in 1998 and as generic sildenafil starting in 2017. Tadalafil was approved as Cialis in 2003 and as generic tadalafil starting in 2018. Both have been used by tens of millions of patients globally with extensive post-marketing safety surveillance. When a 503A pharmacy compounds Ro Sparks or Hims Hard Mints, it’s using FDA-approved active pharmaceutical ingredients (or APIs on the FDA bulk drug substances list), not novel chemistry.

Layer 2: the finished combination product is not FDA approved. The FDA has never reviewed a specific NDA for “sildenafil + tadalafil combined in a sublingual tablet” or “sildenafil + tadalafil chewable mint.” There is no published FDA-vetted prescribing information for the combination form factor, no FDA-mandated labeling, no FDA-required post-marketing surveillance program for these specific products, and no FDA inspection of the finished dosage forms. The combination is a clinical judgment call by the prescriber, not an FDA-endorsed product.

Layer 3: this is not unique to ED — it’s how compounding works. Compounded hormone replacement therapy, compounded GLP-1 medications, compounded pediatric suspensions, compounded ophthalmic preparations, and many dermatology formulations follow the same legal structure: FDA-approved ingredients, non-FDA-approved finished compounded product, dispensed under Section 503A. The compounded ED category isn’t doing anything regulatorily novel. It’s applying a long-standing legal pathway to a high-demand consumer use case.

So when a telehealth ad says “compounded sildenafil-tadalafil — not FDA approved,” that’s an accurate but incomplete statement. The accurate completion is: “the finished compounded combination is not FDA approved, but its active ingredients are FDA-approved drugs with decades of safety data, prepared by a state-licensed pharmacy under federal Section 503A.”

Are they safe? (the science behind sildenafil + tadalafil combinations)

The safety question really has two parts: is the combination of sildenafil and tadalafil safe, and is the compounded delivery (sublingual or chewable) safe?

The combination. Sildenafil and tadalafil are both PDE5 inhibitors. They share a mechanism of action, share a contraindication list, and share most side effects. Combining them in a single dose doesn’t introduce a new pharmacological mechanism — it stacks two drugs that already work on the same enzyme. The combined dose in products like Ro Sparks and Hims Hard Mints is calibrated so that the total PDE5 inhibition is roughly equivalent to a moderate standalone dose of either drug, with the tadalafil component providing duration and the sildenafil component providing onset speed. The combination is sometimes referenced in clinical literature, though the terms “Bimix” and “Trimix” more commonly refer to penile injection formulations (typically papaverine, phentolamine, and prostaglandin E1) rather than oral PDE5 combinations.

There is no published peer-reviewed evidence that combining oral sildenafil and tadalafil at these dose ranges is meaningfully less safe than taking either drug alone at a comparable PDE5-inhibition equivalent. The side-effect profile reported in real-world telehealth datasets — headache, flushing, nasal congestion, dyspepsia, mild visual changes — mirrors the published profiles of standalone sildenafil and tadalafil. Drug interactions are also unchanged: nitrates remain an absolute contraindication, alpha-blockers require caution and dose separation, and recreational nitrites (“poppers”) carry the same life-threatening hypotension risk as with any PDE5 inhibitor.

The delivery. Sublingual sildenafil and sublingual tadalafil have been studied in small clinical trials and have a defensible pharmacokinetic rationale: bypassing first-pass hepatic metabolism can speed onset. Chewable formulations like Hims Hard Mints and BlueChew Max are essentially oral preparations with a non-traditional dosage form — the active ingredients still hit the stomach, but the patient experience is closer to a candy than a pill. Neither delivery route introduces a new safety concern beyond what’s already documented for oral PDE5 inhibitors.

What’s different from compounded semaglutide. Worth flagging: the FDA has issued multiple public warnings about compounded semaglutide products (counterfeit APIs, salt forms not approved for human use, dosing errors leading to hospitalization). The FDA has not issued comparable warnings about compounded sildenafil-tadalafil combinations from licensed 503A pharmacies. That isn’t a guarantee — absence of an FDA warning isn’t the same as an FDA endorsement — but it does suggest the regulator hasn’t seen the same pattern of patient harm in the compounded ED category that it saw in the compounded GLP-1 category.

The 5 real risks you should know about

If compounded ED meds have a safety story, it isn’t about the molecules. It’s about the operational realities of buying a non-FDA-approved finished product from a 503A pharmacy. Here are the five risks that actually matter.

1. Dose variability between batches. Mass-manufactured FDA-approved drugs are tested batch-by-batch to confirm the labeled dose matches what’s in the tablet within tight tolerances. 503A pharmacies are not required to perform that level of batch testing on every compound. In practice, well-run pharmacies do internal quality checks, but there’s more theoretical variation between two Ro Sparks tablets than between two generic Viagra tablets. For ED dosing this usually doesn’t matter clinically. It matters more for narrow-therapeutic-index drugs.

2. Contamination risk if USP standards are skipped. USP chapters 795 (non-sterile compounding) and 797 (sterile compounding) define the cleanliness, equipment, and process standards a compounding pharmacy is supposed to follow. State boards inspect for compliance, but inspection frequency varies. Pharmacies that cut corners on USP 795/797 are where the real contamination cases historically come from — including the 2012 New England Compounding Center fungal meningitis outbreak, which is the high-water mark for what can go wrong when a compounder ignores sterile-compounding standards.

3. No FDA-approved labeling. A compounded product doesn’t ship with the same FDA-mandated patient information leaflet, contraindication table, or boxed warning that an FDA-approved drug carries. The prescribing telehealth platform supplies its own patient materials. Quality varies. A patient on a compounded combo who doesn’t know that nitrates are an absolute contraindication is a patient who got under-informed by the dispensing channel.

4. Insurance generally won’t cover it. Compounded medications are typically excluded from insurance and PBM formularies because they aren’t FDA-approved finished products. Some HSA/FSA administrators will reimburse with a letter of medical necessity, but the default is out-of-pocket. That’s a real cost risk even if it isn’t a clinical safety risk.

5. Ingredient purity is difficult to independently verify. The active pharmaceutical ingredient (API) a 503A pharmacy uses is supposed to come from an FDA-registered API supplier. Tracing that chain as a consumer is hard. The mitigation is to buy from pharmacies that publish their accreditation and ownership structure (Ro Pharmacy, for example, is wholly owned by Ro and PCAB-accredited), rather than from anonymous resellers.

How to evaluate a compounding pharmacy before you buy

Before you fill a compounded ED prescription, the dispensing pharmacy should pass a four-point check.

1. State board of pharmacy licensure. Every U.S. state has a pharmacy board that maintains a public license-lookup tool. The compounding pharmacy should hold an active resident license in the state where it physically operates, plus non-resident licenses in every state it ships to. A legitimate telehealth platform will name the dispensing pharmacy on its order confirmation or in its terms; that name should map to a real licensed entity.

2. PCAB accreditation. The Pharmacy Compounding Accreditation Board, administered by the Accreditation Commission for Health Care (ACHC), is the gold-standard voluntary accreditation for compounding pharmacies. PCAB inspects facilities against USP 795 and 797 standards and renews accreditation periodically. PCAB accreditation isn’t legally required, but its presence is a strong positive signal that the pharmacy takes quality controls seriously. Ro Pharmacy is PCAB-accredited; Hims partner pharmacies vary; BlueChew partner pharmacies vary.

3. Ownership and transparency. Vertically integrated models — where the telehealth platform owns or has a long-term exclusive partnership with the dispensing pharmacy — are easier to audit than fragmented marketplace models. Ro Pharmacy is owned by Ro. That doesn’t make the product inherently better, but it makes the supply chain shorter and easier to evaluate.

4. Real prescriber screening before dispense. The pharmacy should only fill a prescription written after a documented medical intake with a licensed prescriber. If the telehealth flow lets you “buy” compounded sildenafil without a medical questionnaire reviewed by a clinician, that’s a red flag that triggers both regulatory and safety concerns — that’s not a 503A workflow, that’s an unlicensed sale.

Compounded ED products on the market in 2026

Here are the major compounded ED products consumers encounter through legitimate U.S. telehealth in 2026.

Ro Sparks (PCAB-accredited Ro Pharmacy)

Ro Sparks is a sublingual tablet combining sildenafil and tadalafil, dispensed by Ro Pharmacy — Ro’s wholly owned, PCAB-accredited 503A compounding pharmacy. Of the major branded compounded ED products in 2026, Ro Sparks has the cleanest supply chain to audit: one accredited pharmacy, owned by the prescribing platform, with public information on its accreditation status. Sublingual delivery targets 15–30 minute onset, and the product is sold as a four-dose monthly subscription at roughly $48/month, with a $99 intro 8-pack available to new patients. Read our full Ro Sparks review and pricing for the dosing details, side-effect notes, and a breakdown of who Ro Sparks is the right fit for.

See Ro Sparks pricing on Ro →

Hims Hard Mints (partner 503A pharmacies)

Hims Hard Mints are chewable mints combining sildenafil and tadalafil, dispensed by Hims’s partner 503A pharmacies rather than a single in-house facility. Pricing is meaningfully lower than Ro Sparks on a per-dose basis (roughly $6.25–$7.50/dose depending on subscription cadence), and the chewable form factor is more discreet than a sublingual tablet for some users. Accreditation status varies by partner pharmacy, so before ordering it’s worth confirming the dispensing pharmacy named on your order confirmation. See our Ro Sparks vs Hims Hard Mints comparison for the full breakdown on pricing, onset, and which one fits which use case, and visit the Hims profile for the broader platform context.

See Hims Hard Mints pricing →

BlueChew Max (partner 503A pharmacies)

BlueChew Max is the high-dose chewable in BlueChew’s product line, combining sildenafil and tadalafil in a chewable tablet dispensed by BlueChew’s partner 503A pharmacies. BlueChew has been in the chewable ED space longer than either Ro or Hims, and its core proposition is the convenience of a chewable subscription rather than a unique pharmacological angle. For the full breakdown of BlueChew’s plans, pharmacy partners, and how Max compares to BlueChew’s lower-dose tiers, see our BlueChew review and the BlueChew profile.

See BlueChew Max pricing →

Generic compounded sildenafil 25 mg–100 mg (multiple sources)

A handful of boutique telehealth platforms and direct-to-consumer compounding pharmacies offer plain compounded sildenafil — often in dose strengths like 25 mg, 50 mg, or 100 mg, sometimes in non-traditional dosage forms like troches or oral solutions. These are not branded products and quality varies enormously. The four-point pharmacy check above is doubly important here: verify state licensure, look for PCAB accreditation, understand the ownership structure, and confirm a real prescriber wrote the prescription after a medical intake. For most consumers, an FDA-approved generic sildenafil tablet (typically under $2/dose through Costco, Mark Cuban’s Cost Plus Drugs, or a telehealth platform like Ro or Hims) is a more straightforward choice than chasing a compounded version of the same molecule. See our cheaper Ro Sparks alternatives for the FDA-approved generic angle.

Compounded vs FDA-approved: which should you choose?

The honest answer is that for most healthy adult men with straightforward ED, an FDA-approved generic (sildenafil or tadalafil) is the simplest, cheapest, best-documented option. Generic sildenafil 50 mg tablets are available for $1–$3 per dose through cash-pay pharmacy programs in 2026. Generic tadalafil 5 mg daily-use tablets are similarly affordable. Both have FDA-vetted labeling, batch-tested dosing, and broad pharmacist familiarity.

Compounded ED medications make sense when you specifically want something the FDA-approved options don’t offer: a fast-onset sublingual format (Ro Sparks), a discreet chewable form factor (Hims Hard Mints, BlueChew Max), or a combination of sildenafil’s speed plus tadalafil’s duration in a single dose. The trade-off is paying more, accepting non-FDA-approved finished labeling, and depending on the quality controls of a 503A pharmacy rather than a cGMP-regulated manufacturer.

If you’re weighing the molecules themselves rather than the dosage form, our sildenafil vs tadalafil guide walks through the pharmacology trade-off (fast vs long-acting). If you’re trying to pick a telehealth platform to prescribe either type, our roundup of the best online ED treatment services covers the major options including the Ro provider profile.

Insurance, HSA, and FSA coverage for compounded ED medications

Insurance coverage for ED treatment in general is patchy in 2026 — most commercial plans exclude ED medications regardless of compounded vs FDA-approved status. For compounded ED specifically, the answer is essentially “no” across commercial plans, Medicare Part D, and Medicaid in nearly every state.

HSA and FSA reimbursement is more nuanced. The IRS allows HSA/FSA funds to pay for prescription medications that treat a medical condition, and ED qualifies as a medical condition. In practice, HSA/FSA administrators vary in how they handle compounded prescriptions — some reimburse against the pharmacy receipt the same way they would for any prescription, others require a letter of medical necessity from the prescriber, and a few exclude compounded medications entirely. The cleanest path is to ask your HSA/FSA administrator before you order, get any required documentation from your telehealth prescriber, and keep the pharmacy receipt that names the compounding pharmacy and the prescriber.

The practical reality for most patients is that compounded ED medications are an out-of-pocket purchase, priced between FDA-approved branded products (Viagra, Cialis) and FDA-approved generics (generic sildenafil, generic tadalafil). The branded compounded products like Ro Sparks and Hims Hard Mints are priced for the convenience and form factor premium, not for insurance reimbursement.

Frequently Asked Questions

Are compounded ED medications legal?

Yes. Under Section 503A of the federal Food, Drug, and Cosmetic Act, licensed compounding pharmacies can legally prepare medications for individual patients with valid prescriptions from licensed prescribers. Compounded ED medications dispensed through legitimate U.S. telehealth platforms — Ro, Hims, BlueChew — meet that legal framework. What is not legal is unlicensed online sale of “compounded sildenafil” with no prescriber, no medical intake, and no named state-licensed pharmacy. That’s not compounding under Section 503A; that’s unlicensed distribution of a prescription drug.

Is Ro Sparks FDA approved?

No. Ro Sparks is a compounded medication dispensed by Ro Pharmacy, a PCAB-accredited 503A compounding pharmacy. The active ingredients (sildenafil and tadalafil) are FDA-approved as standalone drugs, but the finished sublingual combination tablet is not FDA-reviewed or FDA-approved as a finished product. For the full pricing, dosing, and clinical detail on Ro Sparks specifically, see our Ro Sparks review and pricing.

Are Hims Hard Mints FDA approved?

No. Hims Hard Mints are a compounded chewable medication dispensed by Hims’s partner 503A pharmacies. As with Ro Sparks, the individual active ingredients are FDA-approved drugs with decades of safety data, but the finished chewable combination is not an FDA-approved product. The dispensing pharmacy named on your order should hold active state licensure, and ideally PCAB accreditation.

What’s the difference between 503A and 503B pharmacies?

503A pharmacies are state-licensed compounding pharmacies that prepare medications for individual patients with valid prescriptions. They are regulated primarily by state boards of pharmacy and must follow USP 795/797 standards. 503B facilities are FDA-registered outsourcing facilities that can compound in bulk (typically for hospitals) and must follow current good manufacturing practices (cGMP) — a meaningfully higher regulatory bar. Compounded ED medications dispensed through telehealth in 2026 are almost all from 503A pharmacies, not 503B facilities.

Why aren’t compounded ED meds FDA approved as a finished product?

Because they’re not manufactured — they’re compounded. The FDA approval pathway (an NDA or ANDA) applies to mass-manufactured drug products intended for general distribution. Compounded medications are prepared for specific patients under a different legal pathway (Section 503A) that doesn’t require an NDA. The active ingredients in compounded ED meds went through the FDA approval pathway as standalone drugs decades ago; the finished compounded combination form factor doesn’t go through that pathway again because it doesn’t have to.

Can I get sued or in trouble for buying compounded ED medication?

If you buy through a legitimate U.S. telehealth platform from a state-licensed prescriber, with a state-licensed compounding pharmacy filling the prescription, you are not breaking any U.S. federal or state law. You are purchasing a prescription medication that happens to be compounded rather than mass-manufactured. The legal risk lives on the prescriber and pharmacy side, not the patient side. Where consumers can get into trouble is buying “compounded sildenafil” or similar from international gray-market sites with no prescriber attached — that’s an unlicensed importation issue, not a compounding issue.

How do I check if a compounding pharmacy is legitimate?

Run the four-point check: (1) confirm the pharmacy holds an active resident license with the state board of pharmacy where it physically operates; (2) check for PCAB accreditation through the Accreditation Commission for Health Care’s lookup tool; (3) confirm ownership and that the pharmacy is named on your telehealth order confirmation; (4) confirm your prescription was written after a documented medical intake by a licensed prescriber. If any of those four checks fails, treat the dispensing pharmacy with caution.

Are compounded ED medications cheaper than FDA-approved ones?

Usually no. Generic sildenafil and generic tadalafil are extremely cheap in 2026 — $1–$3 per dose through cash-pay programs. Compounded branded products like Ro Sparks ($12/dose), Hims Hard Mints ($6.25–$7.50/dose), and BlueChew Max sit above generic pricing because you’re paying for the combination, the form factor (sublingual or chewable), and the telehealth bundle. Compounded medications make sense for convenience or form-factor reasons, not for cost.

Does insurance cover compounded ED medications?

Almost never. Most commercial insurance plans, Medicare Part D, and state Medicaid programs exclude both ED medications generally and compounded medications specifically. HSA/FSA reimbursement is sometimes possible with a letter of medical necessity from your prescriber, but rules vary by administrator. The realistic expectation is that compounded ED medications are an out-of-pocket purchase.

Should I choose compounded over FDA-approved sildenafil?

For most healthy adult men with straightforward ED, an FDA-approved generic (generic sildenafil 25–100 mg tablets, or generic tadalafil 5 mg daily-use tablets) is the simplest, cheapest, best-documented option. Compounded products like Ro Sparks, Hims Hard Mints, and BlueChew Max are worth the premium when you specifically want what the FDA-approved options don’t offer: faster onset via sublingual delivery, a discreet chewable form factor, or sildenafil + tadalafil combined in a single dose. The molecules are the same; you’re paying for the dosage form and the convenience.

Sources

• U.S. Food and Drug Administration. “Compounding and the FDA: Questions and Answers” — overview of Section 503A and 503B compounding pathways. fda.gov/drugs/human-drug-compounding (verified May 2026).
• U.S. Food and Drug Administration. “Section 503A of the Federal Food, Drug, and Cosmetic Act.” fda.gov (verified May 2026).
• U.S. Food and Drug Administration. “Bulk Drug Substances Nominated for Use in Compounding Under Section 503A.” (verified May 2026).
• Pharmacy Compounding Accreditation Board (PCAB), administered by the Accreditation Commission for Health Care (ACHC). achc.org/pcab (verified May 2026).
• United States Pharmacopeia. USP Chapter 795 (Pharmaceutical Compounding — Nonsterile Preparations) and USP Chapter 797 (Pharmaceutical Compounding — Sterile Preparations).
• FDA prescribing information for sildenafil (Viagra) and tadalafil (Cialis) — drug interaction and contraindication data.
• Ro Sparks product page, ro.co/erectile-dysfunction/sparks (verified May 2026).
• Hims Hard Mints product page, hims.com/ed/hard-mints (verified May 2026).
• BlueChew product page, bluechew.com (verified May 2026).

Health Disclaimer: BestMedsHub is not a healthcare provider. This article is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified, licensed healthcare professional before starting, stopping, or changing any medication — including compounded ED medications. Do not combine any PDE5 inhibitor (including compounded sildenafil-tadalafil products) with nitrates; the combination can cause life-threatening hypotension. If you experience chest pain, vision changes, hearing loss, or an erection lasting more than four hours after taking any ED medication, seek emergency medical care immediately.